Scientific excellence with commercial acumen
The global bioeconomy is growing rapidly, as businesses realise the potential of biodesign and biomanufacturing. From novel materials to new medicines, data storage and living sensors, synthetic biology offers exciting new opportunities to sense, organise and process matter efficiently and cleanly – if you have the capability to turn theory into practice.
Using state-of-the-art facilities and techniques, our synthetic biology team fuses expertise in biology, chemistry and engineering to convert research-driven discovery into breakthrough products and services.
Background in biodesign
Our synthetic biology capability has grown organically from our long history in healthcare and life-sciences.
Recognising a new era of rational biodesign for products and processes is emerging, we created our synthetic biology division in 2015.
Antha is a programming language for biology that describes and executes complex protocols, driving massive productivity gains during biodesign.
Working in partnership with Synthace, we offer an end-to-end service to help clients launch Antha in their labs, delivering significant workflow efficiency benefits.
Biodesign is not fully predictive today and still requires extensive phenotypic characterisation and testing.
We designed an ultra-high throughput agar array-based system to measure ratiometric fluorescent signals from a library of transformed organisms and automatically identify the best-performing individual strain.
Interested in joining us?
Tech, tools & facilities
Synthetic biology labs
Located in our Cambridge head office, our microbiology lab enables us to genetically modify micro-organisms and characterise them. Our facilities are containment level 2 rated for handling pathogenic strains and our in-house libraries allow rapid modular DNA construct design and assembly. We are particularly interested in building organisms that are biological sensors for healthcare and industrial biotech applications.
SGI BioXP 3200
This system is the world’s first benchtop automated genomic workstation that rapidly synthesizes high-quality, double-stranded DNA fragments and clones into any vector in an overnight run. Its numerous applications include protein production, antibody library generation and cell engineering.
News & insights
Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced the successful close of its Series B funding.
Cambridge Consultants wins two prestigious iF DESIGN AWARDS for Aalto, an injection device for rheumatoid arthritis patients, and Alma a smart cooling case for injectable fertility drugs.
From glowing flowers to decomposing buildings – it was an illuminating week for biotech in the Bay Area
From almost three years of pandemic restrictions to a three-day biology bonanza. Senior Biomedical Engineer Ellen Simmons gets back on the live conference trail with a visit to Built With Biology, formerly SynBioBeta. Here she shares her experiences – and enthusiasm for helping to drive the biotech ecosystem forwards…
- Synthetic biology
Cambridge Consultants partners with Hitachi Central Research Laboratory to address the global challenge of plastic waste
Cambridge Consultants joins the Kyōsō-no-Mori Partnership Program and will work with Hitachi to investigate the applications and business models for applying synthetic biology to plastic recycling.